Use of androgens in patients with renal failure

被引：24

作者：

Johnson, CA ^{[1
]}

机构：

[1] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA

来源：

SEMINARS IN DIALYSIS | 2000年 / 13卷 / 01期

关键词：

D O I：

10.1046/j.1525-139x.2000.00011.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：36 / 39

页数：4

共 29 条

[1] ANDROGENS POTENTIATE THE EFFECTS OF ERYTHROPOIETIN IN THE TREATMENT OF ANEMIA OF END-STAGE RENAL-DISEASE [J].

BALLAL, SH ;

DOMOTO, DT ;

POLACK, DC ;

MARCIULONIS, P ;

MARTIN, KJ .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (01) :29-33

[2]

BERNS JS, 1992, CLIN NEPHROL, V37, P264

[3]

BOYD PR, 1977, CANCER, V40, P1765, DOI 10.1002/1097-0142(197710)40:4<1765::AID-CNCR2820400455>3.0.CO

[4]

2-Y

[5]

DeGowin R L, 1970, Ann Intern Med, V72, P913

[6]

DOMBROS NV, 1994, PERITON DIALYSIS INT, V14, P344

[7] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J].

ESCHBACH, JW ;

EGRIE, JC ;

DOWNING, MR ;

BROWNE, JK ;

ADAMSON, JW .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :73-78

[8]

GAGNON RF, 1997, J AM SOC NEPHROL, V8, pA68

[9] A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients [J].

Gaughan, WJ ;

Liss, KA ;

Dunn, SR ;

Mangold, AM ;

Buhsmer, JP ;

Michael, B ;

Burke, JF .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (04) :495-500

[10] ATHEROGENIC EFFECTS OF ANABOLIC-STEROIDS ON SERUM-LIPID LEVELS - A LITERATURE-REVIEW [J].

GLAZER, G .

ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (10) :1925-1933

← 1 2 3 →